Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
![]() | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
July 8, 2024
editAssessed
edit- Licogliflozin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Mizagliflozin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Rongliflozin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
July 7, 2024
editAssessed
editJuly 6, 2024
editReassessed
edit- CP 47,497 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- Sedaxane (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Assessed
edit- Fermagate (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- RALES (trial) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Removed
edit- Draft:Zosurabalpin (talk) removed.
July 4, 2024
editAssessed
edit- Deprenyl (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Removed
edit- Draft:Clynxx (talk) removed.
July 3, 2024
editReassessed
edit- Donanemab (talk) reassessed. Importance rating changed from Low-Class to Mid-Class. (rev · t)
- Gonadotropin-releasing hormone (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Assessed
edit- Draft:Eunice Ego Mgbeahuruike (talk) assessed. Importance assessed as NA-Class. (rev · t)
July 2, 2024
editAssessed
edit- Draft:LAPaL (talk) assessed. Importance assessed as NA-Class. (rev · t)